Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Mar 25 2002
WASHINGTON, D.C. (March 25, 2002) - The preview program for the BIO 2002 International Biotechnology Convention & Exhibition, including confirmed speakers...
Mar 16 2002
Washington, D.C. (March 16, 2002)- The deadline for on-line registration for those seeking media credentials for BIO 2002 in Toronto is Friday, May 24, 2002....
Mar 13 2002
Washington, D.C. (March 13, 2002)-The Biotechnology Industry Organization (BIO) announced today that discussions with the Food and Drug Administration and the...
Mar 12 2002
WASHINGTON, D.C. (March 12, 2002) - The Interoperable Informatics Infrastructure Consortium (I3C) which was incorporated on Feb. 13, 2002, held its first...
Mar 7 2002
WASHINGTON, D.C. (March 7, 2002) – The advance program for the BIO 2002 International Biotechnology Convention & Exhibition is available online at...
Mar 5 2002
March 5, 2002 (Washington, D.C.)-In conjunction with today’s hearing by the Senate Health, Education, Labor and Pensions Committee on “The Dangers...
Mar 5 2002
WASHINGTON, D.C. (March 5, 2002) - Mary Pendergast, executive vice president for government affairs at Elan Pharmaceuticals, will testify tomorrow on behalf of...
Mar 4 2002
(WASHINGTON, DC) - March 4, 2002 - After a four-month delay, the Centers for Medicare and Medicaid Services (CMS) issued a corrected regulation on pass-through...
Mar 4 2002
PDF copy of Special Section (654 KB)